Total Payments
$1,244
2024 Payments
$166.67
Companies
12
Transactions
17
Medicare Patients
1,836
Medicare Billing
$302,293
Payment Breakdown by Category
Food & Beverage$1,215 (97.6%)
Education$29.49 (2.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,215 | 15 | 97.6% |
| Education | $29.49 | 2 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $253.33 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $186.41 | 2 | $0 (2018) |
| Telix Pharmaceuticals | $148.58 | 1 | $0 (2024) |
| AbbVie, Inc. | $125.94 | 1 | $0 (2019) |
| Pharmacyclics LLC, An AbbVie Company | $100.81 | 1 | $0 (2019) |
| Helsinn Therapeutics (U.S.), Inc. | $95.70 | 1 | $0 (2018) |
| Amgen Inc. | $92.38 | 1 | $0 (2017) |
| Celgene Corporation | $90.05 | 1 | $0 (2017) |
| Clovis Oncology, Inc. | $86.91 | 1 | $0 (2018) |
| PFIZER INC. | $24.96 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $166.67 | 2 | Telix Pharmaceuticals ($148.58) |
| 2022 | $13.56 | 1 | PFIZER INC. ($13.56) |
| 2019 | $462.63 | 5 | Merck Sharp & Dohme Corporation ($217.84) |
| 2018 | $307.74 | 5 | AstraZeneca Pharmaceuticals LP ($96.33) |
| 2017 | $293.76 | 4 | Amgen Inc. ($92.38) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | Merck Sharp & Dohme LLC | WELIREG (Drug) | Education | In-kind items and services | $18.09 | General |
| Category: ONCOLOGY | ||||||
| 01/25/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug) | Food and Beverage | In-kind items and services | $148.58 | General |
| Category: PROSTATE CANCER DIAGNOSIS | ||||||
| 12/19/2022 | PFIZER INC. | XALKORI (Drug), INLYTA, BAVENCIO | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: ONCOLOGY | ||||||
| 10/03/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $108.81 | General |
| Category: ONCOLOGY | ||||||
| 09/10/2019 | AbbVie, Inc. | Venclexta (Drug) | Food and Beverage | In-kind items and services | $125.94 | General |
| Category: Virology | ||||||
| 09/03/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.04 | General |
| 06/11/2019 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $100.81 | General |
| Category: Oncology | ||||||
| 01/16/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $109.03 | General |
| 10/29/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: ONCOLOGY | ||||||
| 10/09/2018 | Helsinn Therapeutics (U.S.), Inc. | AKYNZEO (Drug) | Food and Beverage | In-kind items and services | $95.70 | General |
| Category: ONCOLOGY | ||||||
| 06/12/2018 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $96.33 | General |
| Category: Oncology | ||||||
| 03/13/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $86.91 | General |
| Category: Oncology | ||||||
| 02/27/2018 | PFIZER INC. | SUTENT (Drug) | Education | In-kind items and services | $11.40 | General |
| Category: ONCOLOGY;RESPIRATORY | ||||||
| 10/10/2017 | Celgene Corporation | Abraxane (Drug) | Food and Beverage | In-kind items and services | $90.05 | General |
| Category: Oncology | ||||||
| 08/08/2017 | Amgen Inc. | Vectibix (Biological) | Food and Beverage | In-kind items and services | $92.38 | General |
| Category: Oncology | ||||||
| 06/01/2017 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: BioOncology | ||||||
| 05/09/2017 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $90.08 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 471 | 1,219 | $280,950 | $85,957 |
| 2022 | 8 | 455 | 1,059 | $241,285 | $78,016 |
| 2021 | 9 | 454 | 1,091 | $226,024 | $77,623 |
| 2020 | 11 | 456 | 1,011 | $193,123 | $60,697 |
Total Patients
1,836
Total Services
4,380
Medicare Billing
$302,293
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 180 | 675 | $174,825 | $50,768 | 29.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 60 | 221 | $37,128 | $14,607 | 39.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 134 | 193 | $34,354 | $9,342 | 27.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 24 | 24 | $11,160 | $3,499 | 31.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 23 | $10,051 | $3,332 | 33.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 20 | $7,320 | $2,275 | 31.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 17 | $5,100 | $1,859 | 36.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 22 | 46 | $1,012 | $277.20 | 27.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 191 | 603 | $141,705 | $45,105 | 31.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 59 | 200 | $33,600 | $10,903 | 32.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 35 | 43 | $18,791 | $6,591 | 35.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 103 | 127 | $20,447 | $6,288 | 30.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 26 | 26 | $12,090 | $4,086 | 33.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 20 | $6,640 | $2,260 | 34.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 18 | $4,338 | $1,461 | 33.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 14 | 22 | $3,674 | $1,323 | 36.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 152 | 522 | $116,928 | $39,674 | 33.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 54 | 226 | $37,968 | $13,739 | 36.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 152 | 236 | $36,108 | $11,548 | 32.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 19 | 25 | $10,925 | $4,255 | 38.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 26 | 26 | $11,648 | $4,052 | 34.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 13 | 15 | $4,740 | $1,802 | 38.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 12 | 12 | $3,600 | $1,393 | 38.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 11 | 13 | $2,171 | $673.42 | 31.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 15 | 16 | $1,936 | $487.65 | 25.2% |
About Dr. Timothy Lestingi, M.D
Dr. Timothy Lestingi, M.D is a Hematology & Oncology healthcare provider based in Park Ridge, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114986411.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Timothy Lestingi, M.D has received a total of $1,244 in payments from pharmaceutical and medical device companies, with $166.67 received in 2024. These payments were reported across 17 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,215).
As a Medicare-enrolled provider, Lestingi has provided services to 1,836 Medicare beneficiaries, totaling 4,380 services with total Medicare billing of $302,293. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Park Ridge, IL
- Active Since 03/23/2006
- Last Updated 07/08/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1114986411
Products in Payments
- ILLUCCIX (Drug) $148.58
- KEYTRUDA (Biological) $126.21
- Venclexta (Drug) $125.94
- Imbruvica (Drug) $100.81
- CALQUENCE (Drug) $96.33
- AKYNZEO (Drug) $95.70
- Vectibix (Biological) $92.38
- TAGRISSO (Drug) $90.08
- Abraxane (Drug) $90.05
- Rubraca (Drug) $86.91
- TECENTRIQ (Biological) $21.25
- WELIREG (Drug) $18.09
- XALKORI (Drug) $13.56
- SUTENT (Drug) $11.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Park Ridge
Mrs. Sigrun Hallmeyer, Md, MD
Hematology & Oncology — Payments: $200,542
Hematology & Oncology $200,542
Mr. Jon Richards, M.d, M.D
Hematology & Oncology — Payments: $76,876
Hematology & Oncology $76,876
Dr. Edward James, M.d.,, M.D.,
Hematology & Oncology — Payments: $50,533
Hematology & Oncology $50,533
Dr. Jason Macklis, M.d, M.D
Hematology & Oncology — Payments: $14,505
Hematology & Oncology $14,505
Mrs. Pamela Kaiser, M.d, M.D
Hematology & Oncology — Payments: $13,644
Hematology & Oncology $13,644
Mr. Jacob Bitran, M.d, M.D
Hematology & Oncology — Payments: $5,156
Hematology & Oncology $5,156